Enliven Therapeutics Inc.
ELVN | NASDAQ
$48.87
-$0.58 (-1.17%)
At close: Sep 21, 2026, 4:00 PM ET
$48.75
-$0.12 (-0.25%)
Pre-market:
Sep 22, 2026, 8:10 AM ET
Institutional Ownership
Net OutflowTotal Institutions
180
Total Ownership
99.35%
Capital Flow
-$1.47B
Shares Change
-5.85K
Ownership Distribution
Institutions (99.35%)
Others (0.65%)
Institutional Sentiment
Overall: bullishEquity Sentiment & Activity
bullishNew Positions
66
Increased Positions
129
Reduced Positions
33
Closed Positions
19
New (66)
Increased (129)
Reduced (33)
Closed (19)
Options Sentiment & Activity
bullishPut/Call Ratio
0.318
Call Flow
1,233,400
Put Flow
392,600
Calls (76%)
Puts (24%)
Super Investors
| Super Investor / Fund | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Tudor Investment Corp ET AL | 0.06% 0.00% | < 0.01% | 40.12K | 1.98M |
Top Shareholders
| Institution | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Orbimed Advisors LLC | 12.67% -9.77% | 6.21% +147.25% | 7.96M 0.00% | 312.01M +154.55% | |
| FMR LLC | 10.87% -13.30% | 0.01% +152.67% | 6.83M -3.92% | 267.71M +144.58% | |
| Polar Capital Holdings PLC | 8.07% +30.09% | 0.71% +237.22% | 5.07M +44.18% | 198.58M +267.00% |
Pro Membership
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
Unlimited access
Unlimited access to all data and tools, giving you the edge over everyone else in the market.
Proprietary Stock Rating Score
Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.
Top Wall Street Analyst Ratings
Follow ratings from the best analysts on Wall Street to stay ahead of market moves.
Up to 30 years financial history
We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Add to Watchlist
Select watchlists to add or remove ELVN